Research
Weight-modification trials in older adults: what should the outcome measure be?
Paula Diehr, Anne B Newman, Sharon A Jackson, Lewis Kuller, Neil Powe
Current Controlled Trials in Cardiovascular Medicine 2002, 3:1 (7 January 2002)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]
Review
Clinical significance of cardiovascular dysmetabolic syndrome
Prakash C Deedwania
Current Controlled Trials in Cardiovascular Medicine 2002, 3:2 (7 January 2002)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]
Commentary
The Myocardial Ischemia Reduction with Acute Cholesterol Lowering trial: MIRACuLous or not, it's time to change current practice
Herbert D Aronow
Current Controlled Trials in Cardiovascular Medicine 2002, 3:3 (7 January 2002)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]
Review
Problems in dealing with missing data and informative censoring in clinical trials
Weichung Joseph Shih
Current Controlled Trials in Cardiovascular Medicine 2002, 3:4 (8 January 2002)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
Research
Long-term vitamin E supplementation fails to reduce lipid peroxidation in people at cardiovascular risk: analysis of underlying factors
Chiara Chiabrando, Fausto Avanzini, Claudia Rivalta, Fabio Colombo, Roberto Fanelli, Gaetana Palumbo, Maria Carla Roncaglioni, PPP Collaborative Group on the antioxidant effect of vitamin E
Current Controlled Trials in Cardiovascular Medicine 2002, 3:5 (19 March 2002)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]
Commentary
Pooling, meta-analysis, and the evaluation of drug safety
Michel Lièvre, Michel Cucherat, Alain Leizorovicz
Current Controlled Trials in Cardiovascular Medicine 2002, 3:6 (19 March 2002)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
Review
A Review of the Adverse Effects of Peripheral Alpha-1 Antagonists in Hypertension Therapy
Chris L Bryson MD, Bruce M Psaty MD PhD
Current Controlled Trials in Cardiovascular Medicine 2002, 3:7 (12 April 2002)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]
Research
A Prospective Study of Pravastatin in the Elderly at Risk (PROSPER): Screening Experience and Baseline Characteristics
Ian Ford, Gerard Jan Blauw, Michael B Murphy, James Shepherd, Stuart M Cobbe, Edward LEM Bollen, Brendan M Buckley, J Wouter Jukema, Michael Hyland, Allan Gaw, A Margot Lagaay, Ivan J Perry, Peter Macfarlane, John Norrie, A Edo Meinders, Brian J Sweeney, Chris J Packard, Rudi GJ Westendorp, Cillian Twomey, David J Stott, the PROSPER Study Group
Current Controlled Trials in Cardiovascular Medicine 2002, 3:8 (20 May 2002)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]
Research
A randomized controlled trial of an extensive lifestyle management intervention (ELMI) following cardiac rehabilitation: study design and baseline data
Scott A Lear, Andrew Ignaszewski, Wolfgang Linden, Anka Brozic, Marla Kiess, John J Spinelli, P Haydn Pritchard, Jiri J Frohlich
Current Controlled Trials in Cardiovascular Medicine 2002, 3:9 (12 November 2002)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]
Research
Validation of Heart Failure Events in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants Assigned to Doxazosin and Chlorthalidone
Linda B Piller, Barry R Davis, Jeffrey A Cutler, William C Cushman, Jackson T Wright Jr, Jeff D Williamson, Frans HH Leenen, Paula T Einhorn, Otelio S Randall, John S Golden, L Julian Haywood, the ALLHAT Collaborative Research Group
Current Controlled Trials in Cardiovascular Medicine 2002, 3:10 (14 November 2002)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]
|
